RelB, a subunit of the nuclear factor-κβ (NFκβ), is known to be expressed at high levels in aggressive BC, especially in TNBC, resulting in the induction of Bcl-2 and cyclin D1 (CCND1) expression as well as promotion of cell cycle progression and cell proliferation [70]. The gene discussed is RELB; the disease is breast cancer.